Trial Profile
Phase I/II study of the safety of subcutaneous interferon gamma-1b combined with rituximab in patients with low grade/follicular non-Hodgkin's lymphoma
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon gamma-1b (Primary) ; Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2005 New trial record.